Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia
暂无分享,去创建一个
Tatiana Foroud | Nathan Pankratz | T. Foroud | A. Rudolph | N. Pankratz | C. Shults | P. Conneally | C. Halter | W. Nichols | P Michael Conneally | Clifford W Shults | Cheryl Halter | William C Nichols | Lisa Byder | Alice Rudolph | Lisa Byder
[1] E. Larson,et al. Effect of Education on the Mini‐Mental State Examination as a Screening Test for Dementia , 1991, Journal of the American Geriatrics Society.
[2] A. Lees,et al. What features improve the accuracy of clinical diagnosis in Parkinson's disease , 1992, Neurology.
[3] J. Hughes,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. , 1992, Journal of neurology, neurosurgery, and psychiatry.
[4] W. Koller,et al. When does Parkinson's disease begin? , 1992, Neurology.
[5] J. Haines,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. , 1993, Science.
[6] D R Rajput,et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[7] A. M. Saunders,et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease , 1994, Nature Genetics.
[8] D. Clair,et al. Apolipoprotein E ϵ4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls , 1994, Neuroscience Letters.
[9] A. Brookes,et al. Apolipoprotein E epsilon 4 allele frequency in patients with Lewy body dementia, Alzheimer's disease and age-matched controls. , 1994, Neuroscience letters.
[10] B. Hyman,et al. Alzheimer's disease with and without coexisting Parkinson's disease changes , 1995, Neurology.
[11] G. Schellenberg,et al. Modulation of the age at onset of Parkinson's disease by apolipoprotein E genotypes , 1997, Annals of neurology.
[12] J. Chapman,et al. Apolipoprotein E4 in Parkinson Disease and Dementia: New Data and Meta‐Analysis of Published Studies , 1998, Alzheimer disease and associated disorders.
[13] A. Quattrone,et al. Apolipoprotein E polymorphisms and Parkinson's disease , 1999, Neuroscience Letters.
[14] A. Hofman,et al. APOE and the risk of PD with or without dementia in a population-based study , 2000, Neurology.
[15] D. Schaid,et al. Case‐control study of debrisoquine 4‐hydroxylase, n‐acetyltransferase 2, and apolipoprotein e gene polymorphisms in Parkinson's disease , 2000, Movement disorders : official journal of the Movement Disorder Society.
[16] J. Nutt,et al. Age at onset of Parkinson disease and apolipoprotein E genotypes. , 2002, American journal of medical genetics.
[17] L. Seeberger,et al. Linkage stratification and mutation analysis at the parkin locus identifies mutation positive Parkinson's disease families , 2002, Journal of medical genetics.
[18] J. Perlmutter,et al. Parkinson's disease and apolipoprotein E: possible association with dementia but not age at onset. , 2002, Genomics.
[19] T. Foroud,et al. Reliability of reported age at onset for Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[20] M. Emre. Dementia associated with Parkinson's disease , 2003, The Lancet Neurology.
[21] J. Haines,et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease , 2004, Neurology.
[22] S. Lipton,et al. Molecular pathways to neurodegeneration , 2004, Nature Medicine.
[23] J. Brandt,et al. Motor signs during the course of Alzheimer disease , 2004, Neurology.
[24] Yaakov Stern,et al. Cognitive reserve: Implications for diagnosis and prevention of Alzheimer’s disease , 2004, Current Neurology and Neuroscience Reports.
[25] T. Foroud,et al. Genetics of Parkinson disease , 2004 .
[26] O. Lopez,et al. Genetic association between the APOE*4 allele and Lewy bodies in Alzheimer disease , 2005, Neurology.